PTH logo

Invesco DWA Healthcare Momentum ETF (PTH)

$55.90

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PTH

AUM

$276169218

P/E ratio

19.3

Dividend yield

2.4913%

Expense ratio

0.6%

Beta

0.829098

Price on PTH

Previous close

$57.32

Today's open

$57.23

Day's range

$55.89 - $57.33

52 week range

$46.09 - $64.10

Profile about PTH

show more

Headquarters

US

Exchange

NASDAQ Global Market

Issue type

Exchange-Traded Fund

PTH industries and sectors

Industries

Health

News on PTH

PTH: Caution Merited Given Weak Risk-Adjusted Returns

I initiate coverage of the Invesco Dorsey Wright Healthcare Momentum ETF with a Hold rating. PTH's biotechnology-heavy portfolio has fairly strong weighted average Quant and Wall Street ratings, which means it might outmaneuver IVV into 2027. However, compared to IVV and XLV, its performance since 2014 has been lackluster, especially in terms of risk-adjusted returns and maximum drawdowns.

news source

Seeking Alpha • Nov 14, 2026

news preview

Should You Invest in the Invesco Dorsey Wright Healthcare Momentum ETF (PTH)?

If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the Invesco Dorsey Wright Healthcare Momentum ETF (PTH), a passively managed exchange traded fund launched on October 12, 2006.

news source

Zacks Investment Research • Sep 28, 2026

news preview

Medical Technology Stocks: Innovation Endures As Valuations Reset

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

news source

Seeking Alpha • May 2, 2026

news preview

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.

news source

Seeking Alpha • Apr 12, 2026

news preview

Can Forgotten Biotech Break Out?

After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.

news source

Seeking Alpha • Apr 11, 2026

news preview

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

news source

Seeking Alpha • Nov 11, 2025

news preview

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs

The U.S. Food and Drug Administration's recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.

news source

Benzinga • Sep 18, 2025

news preview

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

news source

Seeking Alpha • May 30, 2025

news preview

PTH: A Health Care Headache Worth Selling

PTH is comprised of 30+ Health Care stocks selected based on a proprietary momentum-based model. Its expense ratio is 0.60% and the ETF has $115 million in assets under management. The strategy relies on technical analysis, but that's not necessarily the issue. Instead, PTH reconstitutes quarterly, forcing managers to wait to buy stocks only after they've made their massive gains. PTH's current holdings illustrate this point perfectly. Although they've gained 51% over the last six months, the ETF itself has declined by 12% over the same period.

news source

Seeking Alpha • Mar 10, 2025

news preview

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

news source

Seeking Alpha • Feb 25, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Invesco DWA Healthcare Momentum ETF

Open an M1 investment account to buy and sell Invesco DWA Healthcare Momentum ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PTH on M1